Cargando…
Urgent care study of the LumiraDx SARS-CoV-2 Ag Test for rapid diagnosis of COVID-19
BACKGROUND: Testing individuals suspected of severe acute respiratory syndrome–like coronavirus 2 (SARS-CoV-2) infection is essential to reduce the spread of disease. The purpose of this retrospective study was to determine the false negativity rate of the LumiraDx SARS-CoV-2 Ag Test when utilized f...
Autores principales: | Gresh, Jared, Kisner, Harold, DuChateau, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709539/ https://www.ncbi.nlm.nih.gov/pubmed/34952653 http://dx.doi.org/10.1186/s41512-021-00113-7 |
Ejemplares similares
-
Performance Evaluation of the Quantitative Point-of-Care LumiraDx d-Dimer Test
por: Ellis, Jayne E., et al.
Publicado: (2021) -
Utilidad del test de antígenos SARS-COV-2 de LumiraDx™ en centros residenciales
por: Domínguez Fernández, Mercedes, et al.
Publicado: (2022) -
Evaluation of the analytical sensitivity of ACON and LumiraDx SARS-CoV-2 rapid antigen tests using samples with presumed Omicron variant
por: Karon, Brad S., et al.
Publicado: (2023) -
Performance of the LumiraDx Microfluidic Immunofluorescence Point-of-Care SARS-CoV-2 Antigen Test in Asymptomatic Adults and Children
por: Drain, Paul, et al.
Publicado: (2021) -
Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2
por: Krüger, Lisa J., et al.
Publicado: (2021)